Efforts to limit access to the abortion drug mifepristone have gotten boost from a federal judge who took the bench

After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal suit in Texas aimed at mifepristone, one drug in a two-drug regimen used in medication abortions.

A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide.

Since the U.S. Supreme Court’s decision in 2022 to allow states to regulate abortion access, support for expanded access to abortion pills has significantly increased, including among those living in states with abortion bans,